Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
Status:
Not yet recruiting
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical
community. The investigators routinely see patients who cannot afford PDE-5 inhibitors and
absorbent pads after prostate surgery, which help with sexual rehabilitation after surgery
and reduced quality of life secondary to urinary incontinence after surgery, respectively.
The goal of our study is to provide PDE-5 inhibitors and absorbent pads to patients who would
be unable to afford them. We hypothesize that providing PDE-5 inhibitor (Tadalafil 4mg taken
every other day for 6 months) and absorbent pads for 6 months will result in improved sexual
health and management of urinary incontinence after radical prostatectomy.